bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-3403

Order Name:
ACT BRCA, Tissue (FFPE) **

 
Useful For:
Detects BRCA1/2 somatic mutations in tumor samples.
For breast, ovarian, pancreatic and prostate cancer.
Evaluates targeted therapy.
 
Methodology:
Next-generation sequencing (NGS)
 
AliasesName:
ACTBRCA, Tissue
BRCA1, BRCA2 Tissue
BRCA1/2 Tissue FFPE
 
 
 
Test Code:
090-71-3403

Order Name:
ACT BRCA, Tissue (FFPE) **

 
Collection Specimen Or Container:
Tissue/ Formalin-fixed paraffin-embedded (FFPE) block

Document Required
Filled Requisition Form & Sign Consent 
 
Specimen Testing Type:
FFPE 5-20 unstained slides (10 µm /slide, with total serface area ≥ 125 mm²) + 1 H&E slide (5 µm), (Malignant cell content ≥ 10% minimum, ≥ 30% preferred)
 
Sub Mission Container:
Specimen collection kit
 
Rejection Criteria:
Specimen was insufficient for testing (Low cellularity, Low tumor purity, DNA highly fragmentation) will be rejected.
 
 
 
Test Code:
090-71-3403

Order Name:
ACT BRCA, Tissue (FFPE) **

 
Method detail:
Next-generation sequencing (NGS)
 
Schedule:
N/A **Sent out to ACT Genomics, Taiwan
 
Turnaround Time:
Received specimen to report 20-30 days (Slide received to report)
 
Performing Location:
ACT Genomics
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-3403

Order Name:
ACT BRCA, Tissue (FFPE) **

 
 
Reference Value:
An interpretive report will be provided.
 
Interpretation:
For every report, ACT Genomics provides one-on-one report consultation for ordering physician. Report offers clinically significant insights through logically-organized content and intuitive graphics.
 
Clinical Reference:
www.actgenomics.com (Retrieved: 15 Apr 2019)